Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis

Naunyn Schmiedebergs Arch Pharmacol. 2016 Nov;389(11):1159-1169. doi: 10.1007/s00210-016-1278-7. Epub 2016 Jul 22.

Abstract

Acute pulmonary embolism (APE) has a very high mortality rate, especially at cardiac arrest and even after the return of spontaneous circulation (ROSC). This study investigated the protective effect of the angiotensin-converting enzyme (ACE) inhibitor captopril on postresuscitation hemodynamics, in a porcine model of cardiac arrest established by APE. Twenty-nine Beijing Landrace pigs were infused with an autologous thrombus leading to cardiac arrest and subjected to standard cardiopulmonary resuscitation and thrombolysis. Ten resuscitated pigs were randomly and equally apportioned to receive either captopril (22.22 mg/kg) infusion or the same volume saline, 30 min after ROSC. Hemodynamic changes and ACE-Ang II-angiotensin II type 1 receptor (AT1R) and ACE2/Ang-(1-7)/Mas receptor axis levels were determined. APE was associated with a decline in mean arterial pressure and a dramatic increase in pulmonary artery pressure and mean right ventricular pressure. After ROSC, captopril infusion was associated with significantly lower mean right ventricular pressure and systemic and pulmonary vascular resistance, faster heart rate, and higher Ang-(1-7) levels, ACE2/ACE, and Ang-(1-7)/Ang II, compared with the saline infusion. The ACE2/Ang-(1-7)/Mas pathway correlated negatively with external vascular lung water and pulmonary vascular permeability and positively with the right cardiac index. In conclusion, in a pig model of APE leading to cardiac arrest, captopril infusion was associated with less mean right ventricular pressure overload after resuscitation, compared with saline infusion. The reduction in systemic and pulmonary vascular resistance associated with captopril may be by inhibiting the ACE-Ang II-AT1R axis and activating the ACE2/Ang-(1-7)/Mas axis.

Keywords: ACE2/Ang-(1-7)-Mas axis; Acute pulmonary embolism; Captopril; Cardiac arrest; Restoring spontaneous circulation.

MeSH terms

  • Angiotensin I / metabolism*
  • Angiotensin-Converting Enzyme 2
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Animals
  • Arterial Pressure / drug effects
  • Biomarkers / blood
  • Capillary Permeability / drug effects
  • Captopril / pharmacology*
  • Cardiopulmonary Resuscitation*
  • Disease Models, Animal
  • Enzyme Activation
  • Female
  • Heart Arrest / blood
  • Heart Arrest / enzymology
  • Heart Arrest / physiopathology
  • Heart Arrest / therapy*
  • Hemodynamics / drug effects*
  • Male
  • Peptide Fragments / metabolism*
  • Peptidyl-Dipeptidase A / metabolism*
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins / metabolism*
  • Pulmonary Artery / drug effects
  • Pulmonary Artery / physiopathology
  • Pulmonary Edema / enzymology
  • Pulmonary Edema / physiopathology
  • Pulmonary Edema / prevention & control
  • Pulmonary Embolism / blood
  • Pulmonary Embolism / enzymology
  • Pulmonary Embolism / physiopathology
  • Pulmonary Embolism / therapy*
  • Receptors, G-Protein-Coupled / metabolism*
  • Renin-Angiotensin System / drug effects
  • Signal Transduction / drug effects
  • Sus scrofa
  • Thrombolytic Therapy
  • Time Factors
  • Vascular Resistance / drug effects
  • Ventricular Function, Right / drug effects
  • Ventricular Pressure / drug effects

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Biomarkers
  • Peptide Fragments
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • Receptors, G-Protein-Coupled
  • Angiotensin I
  • Captopril
  • Peptidyl-Dipeptidase A
  • Angiotensin-Converting Enzyme 2
  • angiotensin I (1-7)